Neldaleucel

Cell therapy

Also known as MT-601

Earlyevidence

Evidence outlook

Early-stage evidence only

Phase 1 / first-in-human studies establish safety, tolerability, and dosing; they are not designed to demonstrate efficacy, so no evidence signal is assigned yet. The first graded signal arrives with a completed confirmatory readout.

How the evidence outlook works ↗

All registered studies

Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase.

Phase 1 (2)
Relapsed/Refractory Non-Hodgkin Lymphoma
Other / comorbidity
NCT06549751 · Marker Therapeutics, Inc.
2026-07-16 – 2028-09-16 · Pancreas Cancer, Pancreatic Cancer Metastatic, Pancreatic Cancer (Unresectable)
What this study did

Competitive landscape

This drug's own stage for Relapsed/Refractory Non-Hodgkin Lymphoma: Phase 1. Competitors below are sorted furthest-along first.

DrugStageModalityMechanismEvidence signalReported efficacygraded featured trials
Neldaleucel: this drugPhase 1Cell therapySix tumor-associated antigensnot yet gradedNo reviewed efficacy summary in this indication
PF-05280586ApprovedBiologic (subtype unspecified)CD20not yet gradedNo reviewed efficacy summary in this indication

Upcoming events

(2 total)

Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.

Follow Neldaleucel to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.

Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

2028 (2)
February 2028 (1)
Phase 1Relapsed/Refractory Non-Hodgkin LymphomaRecruiting
Est. primary completion 2028-02-28 · NCT05798897 · CT.gov ↗
What to watch
July 2028 (1)
Phase 1Pancreas Cancer, Pancreatic Cancer Metastatic, Pancreatic Cancer (Unresectable)Not yet recruiting
Est. primary completion 2028-07-16 · NCT06549751 · CT.gov ↗
What to watch

See the full readout calendar ↗